FDA Orders Blindness Warning on Ozempic and Zepbound
The FDA is requiring every GLP-1 drug, including Ozempic and Zepbound, to warn about a rare eye condition that can cause permanent vision loss.
By: hammadkhaksarADاشتہار / AdvertisementGoogle Ad
#FDA
3 articles found under this topic
FDA Approves New Blood Thinner to Cut Repeat Strokes by 26%
The FDA has approved Sunharbo, the first drug to block clotting protein Factor XIa — a once-daily pill that cut repeat strokes by 26% in a major trial.
By: hammadkhaksar
FDA Orders Eye-Risk Warnings on Ozempic and Zepbound
The US Food and Drug Administration has ordered new warnings about a rare risk of sudden vision loss on popular weight-loss and diabetes drugs including Ozempic and Zepbound.
By: hammadkhaksar